Deep Insight
VC Fund
Herzliya, Israel
Deep Insight is a VC fund in Herzliya focused on Biotechnology and Health Care. Deep Insight is the first Israeli venture fund to invest only in Deep Tech at all stages and across all sectors, including semiconductors and any scientific or technological breakthrough in physics or life science.
- Total investments:
- 17
- Last investment:
- Lead investor:
- 35%
Last updated:
For AI agents: llms.txt
Industries Deep Insight invests in
BiotechnologyHealth CareMedicalSoftwareElectronics
Stages Deep Insight invests in
Series BSeries AFunding RoundSeries CSeries D
Countries Deep Insight invests in
IsraelUnited StatesUnited Kingdom
Round sizes
Series A $16M–$85MSeries B $26M–$74M
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
2 more contacts available
Round size
- Series A
- $16M–$85M
- Series B
- $26M–$74M
Investment Focus
Industry
- Biotechnology 6 (35%)
- Health Care 4 (24%)
- Medical 2 (12%)
- Software 2 (12%)
- Electronics 2 (12%)
Stage
- Series B 6 (35%)
- Series A 4 (24%)
- Funding Round 2 (12%)
- Series C 1 (6%)
- Series D 1 (6%)
Country
- Israel 8 (47%)
- United States 3 (18%)
- United Kingdom 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Eyal Kishon
Managing Partner
|
Managing Partner | Total investments: 16 | Find email | |
Barak Ben-Eliezer
Co-Founder & Managing Partner
|
Co-Founder & Managing Partner | Total investments: 7 | Find email | |
Tal Shahar
Principal
|
Principal | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Scala Biodesign
|
Scala Biodesign offers partners a one-of-a-kind computational solution to drastically boost the value of proteins and accelerate their development into commercial products. | $16M / Series A / Mar 31, 2026 | |
Addionics
|
Addionics is creating next-generation batteries through intelligent 3D battery architecture and engineering. It provides specialized improved rechargeable batteries by redesigning their architecture.With the largest markets in mind, the company invents new energy storage with higher energy density, lower charging time, and improved heat safety.Addionics is developing a new technology that transforms how energy is stored and delivered, positively impacting the environment. Today, the company is accelerating the development and scale-up of its proprietary technology to create the next generation of batteries to power the future. It provides specialized improved rechargeable batteries by redesigning their architecture. | $39M / Series B / Jul 25, 2024 | |
Averna Therapeutics
|
Exsilio's method is based on naturally occurring genetic elements that can accurately insert new genes into cells via RNA intermediate templates. Exsilio employs predictive in-silico modeling and wet lab-based experiments to create such elements for accurate insertion of therapeutic genes into safe harbor regions of disease-relevant cells. | $85M / Series A / Jun 25, 2024 | |
Magnus Metal
|
MagnusMetal embarks traditional casting into the 21st century with the patent-pending digital casting. | $74M / Series B / Apr 18, 2024 | |
Greeneye Technology
|
Greeneye utilizes Artificial Intelligence to disrupt the agricultural pest control process, transitioning from the current practice of broadcast and wasteful spraying to precise and selective spraying of herbicides. Greeneye developed a proprietary selective spraying (SPP) system that turns every sprayer into a smart machine with seamlessintegration, Greeneye’s SSP system can detect weeds and spray them precisely in real-time, reducing up to 90% of herbicide usage. Demo - https://www.youtube.com/watch?v=iCOuTemX_cc&feature=youtu.beGreeneye is a leading technology company with a focus in precision agriculture, established in 2017 and based in Tel-Aviv, Israel. Greeneye has a multidisciplinary team with expertise in computer vision, artificial intelligence, agronomy, mechanical engineering, spraying applications, etc. We work with an extraordinary group of talented and visionary people who are committed to provide sustainable solutions for farmers around the world. | $20M / Venture - Series Unknown / Apr 17, 2024 | |
|
Greeneye Technology
|
Greeneye utilizes Artificial Intelligence to disrupt the agricultural pest control process, transitioning from the current practice of broadcast and wasteful spraying to precise and selective spraying of herbicides. Greeneye developed a proprietary selective spraying (SPP) system that turns every sprayer into a smart machine with seamlessintegration, Greeneye’s SSP system can detect weeds and spray them precisely in real-time, reducing up to 90% of herbicide usage. Demo - https://www.youtube.com/watch?v=iCOuTemX_cc&feature=youtu.beGreeneye is a leading technology company with a focus in precision agriculture, established in 2017 and based in Tel-Aviv, Israel. Greeneye has a multidisciplinary team with expertise in computer vision, artificial intelligence, agronomy, mechanical engineering, spraying applications, etc. We work with an extraordinary group of talented and visionary people who are committed to provide sustainable solutions for farmers around the world. | $20M / Venture - Series Unknown / Apr 17, 2024 | |
Ramon.Space
|
Ramon.Space builds space-resilient super-computer systems that bring cloud computing to space. The New Space market is driven by privatization and commercial goals that give birth to new space services and applications. The demand for significant processing power, storage and better intelligence creates a huge market potential. Yet, the scale ofcomputing capabilities required for New Space applications is not available today due to environmental challenges such as radiation and extreme temperatures. Powered by its unique AI/ML processors, Ramon.space’s software-defined systems enable the realizations of earth-like computing capabilities in space. The company's proven technology is already deployed in space, and is used in many satellites and in more than 50 space missions across the solar system - with zero failures. With its innovative technology and an enthusiastic team that constantly pushes the boundaries of technology, Ramon.Space is set to lead the digital transformation of space. | $26M / Jun 28, 2023 | |
|
Ramon.Space
|
Ramon.Space builds space-resilient super-computer systems that bring cloud computing to space. The New Space market is driven by privatization and commercial goals that give birth to new space services and applications. The demand for significant processing power, storage and better intelligence creates a huge market potential. Yet, the scale ofcomputing capabilities required for New Space applications is not available today due to environmental challenges such as radiation and extreme temperatures. Powered by its unique AI/ML processors, Ramon.space’s software-defined systems enable the realizations of earth-like computing capabilities in space. The company's proven technology is already deployed in space, and is used in many satellites and in more than 50 space missions across the solar system - with zero failures. With its innovative technology and an enthusiastic team that constantly pushes the boundaries of technology, Ramon.Space is set to lead the digital transformation of space. | $26M / Series B / Jun 28, 2023 | |
Bionaut Labs
|
Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality. By creating a new medical modality of remote-controlled micro-robots called Bionauts, the company can transform the way the biopharmaceutical industry develops treatments, allowing them to engineer the therapeutic index forefficacy and maintain safety.Bionaut Labs is focused on helping patients suffering from debilitating brain diseases who have few available treatment options. The anatomical targeting capabilities of the Bionaut platform make new therapeutics technologies such as gene therapy, CRISPR-Cas9, and oncolytic viruses viable in challenging clinical settings. | $43.2M / Series B / Nov 28, 2022 | |
MediWound
|
MediWound is a biotechnology niche-specialty company. Established in 2001, MediWound is focused on developing, manufacturing, and globally commercializing innovative products that address unmet needs in the fields of severe burns and chronic wound management.MediWound’s goal is to provide healthcare professionals and patients with its innovativeburn wound eschar removal agent, NexoBrid. NexoBrid successfully completed clinical development in hospitalized burn wounds and is approved and ready to launch in Europe. | $30M / Post-IPO Equity / Sep 22, 2022 | |
| See all 17 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
SaaS Investors
99,274 investors
Software Investors
50,021 investors
Health Care Investors
43,014 investors
Hardware Investors
40,144 investors
Consumer Investors
32,380 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Medical Investors
18,848 investors
SaaS VC Funds
61,208 investors
FAQ
What does Deep Insight invest in?
Deep Insight invests primarily in Biotechnology, Health Care and Medical startups, most often at Series B and Series A stage. Most of the 17 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Deep Insight's check size?
Deep Insight typically joins rounds of $16M–$85M at Series A and $26M–$74M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Deep Insight participates in.
How do I contact Deep Insight?
Public channels for Deep Insight include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Deep Insight?
The team at Deep Insight includes Eyal Kishon (Managing Partner), Barak Ben-Eliezer (Co-Founder & Managing Partner) and Tal Shahar (Principal). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
